Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis-Report 2: Guidelines for Initiating Antitubercular Therapy in Anterior Uveitis, Intermediate Uveitis, Panuveitis, and Retinal Vasculitis.


Journal

Ophthalmology
ISSN: 1549-4713
Titre abrégé: Ophthalmology
Pays: United States
ID NLM: 7802443

Informations de publication

Date de publication:
02 2021
Historique:
received: 28 01 2020
revised: 03 06 2020
accepted: 22 06 2020
pubmed: 1 7 2020
medline: 31 7 2021
entrez: 1 7 2020
Statut: ppublish

Résumé

The Collaborative Ocular Tuberculosis Study (COTS), supported by the International Ocular Inflammation Society, International Uveitis Study Group, and Foster Ocular Immunological Society, set up an international, expert-led consensus project to develop evidence- and experience-based guidelines for the management of tubercular uveitis (TBU). The absence of international agreement on the use of antitubercular therapy (ATT) in patients with TBU contributes to a significant heterogeneity in the approach to the management of this condition. Consensus statements for the initiation of ATT in TBU were generated using a 2-step modified Delphi technique. In Delphi step 1, a smart web-based survey based on background evidence from published literature was prepared to collect the opinion of 81 international experts on the use of ATT in different clinical scenarios. The survey included 324 questions related to tubercular anterior uveitis (TAU), tubercular intermediate uveitis (TIU), tubercular panuveitis (TPU), and tubercular retinal vasculitis (TRV) administered by the experts, after which the COTS group met in November 2019 for a systematic and critical discussion of the statements in accordance with the second round of the modified Delphi process. Forty-four consensus statements on the initiation of ATT in TAU, TIU, TPU, and TRV were obtained, based on ocular phenotypes suggestive of TBU and corroborative evidence of tuberculosis, provided by several combinations of immunologic and radiologic test results. Experts agreed on initiating ATT in recurrent TAU, TIU, TPU, and active TRV depending on the TB endemicity. In the presence of positive results for any 1 of the immunologic tests along with radiologic features suggestive of past evidence of tuberculosis infection. In patients with a first episode of TAU, consensus to initiate ATT was reached only if both immunologic and radiologic test results were positive. The COTS consensus guidelines were generated based on the evidence from published literature, specialists' opinions, and logic construction to address the initiation of ATT in TBU. The guidelines also should inform public policy by adding specific types of TBU to the list of conditions that should be treated as tuberculosis.

Identifiants

pubmed: 32603726
pii: S0161-6420(20)30598-4
doi: 10.1016/j.ophtha.2020.06.052
pii:
doi:

Substances chimiques

Antitubercular Agents 0
Glucocorticoids 0

Types de publication

Consensus Development Conference Journal Article Practice Guideline

Langues

eng

Sous-ensembles de citation

IM

Pagination

277-287

Subventions

Organisme : Medical Research Council
ID : MC_PC_19005
Pays : United Kingdom

Investigateurs

Rupesh Agrawal (R)
Ilaria Testi (I)
Baharam Bodaghi (B)
Talin Barisani-Asenbauer (T)
Peter McCluskey (P)
Aniruddha Agarwal (A)
John H Kempen (JH)
Amod Gupta (A)
Justine R Smith (JR)
Yew Sen Yuen (YS)
Sarakshi Mahajan (S)
Mamta Agarwal (M)
Manisha Agarwal (M)
Ashutosh Aggarwal (A)
Kanika Aggarwal (K)
Mukesh Agrawal (M)
Hassan Al-Dhibi (H)
Sofia Androudi (S)
Fatma Asyari (F)
Manohar Babu Balasundaram (MB)
Kalpana Babu Murthy (KB)
Edoardo Baglivo (E)
Alay Banker (A)
Reema Bansal (R)
Soumyava Basu (S)
Digamber Behera (D)
Jyotirmay Biswas (J)
Ester Carreño (E)
Laure Caspers (L)
Soon Phaik Chee (SP)
Romi Chhabra (R)
Luca Cimino (L)
Luz Elena Concha Del Rio (LE)
Emmett T Cunningham (ET)
Andrè Luiz Land Curi (AL)
Dipankar Das (D)
Janet Davis (J)
Marc DeSmet (M)
Ekaterina Denisova (E)
Alastair K Denniston (AK)
Marie-Hélène Errera (MH)
Alejandro Fonollosa (A)
Amala George (A)
Debra A Goldstein (DA)
Yan Guex Crosier (YG)
Dinesh Visva Gunasekeran (DV)
Avinash Gurbaxani (A)
Alessandro Invernizzi (A)
Hazlita M Isa (HM)
Shah M D Islam (SMD)
Nicholas Jones (N)
Deeksha Katoch (D)
Moncef Khairallah (M)
Amit Khosla (A)
Michal Kramer (M)
Amitabh Kumar (A)
Atul Kumar (A)
Rina La Distia Nora (R)
Richard Lee (R)
Careen Lowder (C)
Saurabh Luthra (S)
Padmamalini Mahendradas (P)
Dorine Makhoul (D)
Shahana Mazumdar (S)
Salil Mehta (S)
Elisabetta Miserocchi (E)
Manabu Mochizuki (M)
Oli S Mohamed (OS)
Cristina Muccioli (C)
Marion R Munk (MR)
Somasheila Murthy (S)
Shishir Narain (S)
Heloisa Nascimento (H)
Piergiorgio Neri (P)
Myhanh Nguyen (M)
Annabelle A Okada (AA)
Pinar Ozdal (P)
Alan Palestine (A)
Francesco Pichi (F)
Dhananjay Raje (D)
S R Rathinam (SR)
Andres Rousselot (A)
Ariel Schlaen (A)
Shobha Sehgal (S)
H Nida Sen (H)
Aman Sharma (A)
Kusum Sharma (K)
Samir S Shoughy (SS)
Nirbhai Singh (N)
Ramandeep Singh (R)
Masoud Soheilian (M)
Sudharshan Sridharan (S)
Jennifer E Thorne (JE)
Christoph Tappeiner (C)
Stephen Teoh (S)
Maria Sofia Tognon (MS)
Ilknur Tugal-Tutkun (I)
Mudit Tyagi (M)
Harvey Uy (H)
Daniel Vitor Vasconcelos Santos (DV)
Natasa Vidovic Valentincic (NV)
Mark Westcott (M)
Ryoji Yanai (R)
Bety Yanez Alvarez (BY)
Rahman Zahedur (R)
Manfred Zierhut (M)
Zheng Xian (Z)
Onn Min Kon (OM)
Quan Dong Nguyen (QD)
Carlos Pavesio (C)
Vishali Gupta (V)

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2020 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Auteurs

Rupesh Agrawal (R)

National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore, Republic of Singapore; Moorfields Eye Hospital and Biomedical Research Centre, Institute of Ophthalmology, University College London, London, United Kingdom; Singapore Eye Research Institute, Singapore, Republic of Singapore.

Ilaria Testi (I)

Moorfields Eye Hospital and Biomedical Research Centre, Institute of Ophthalmology, University College London, London, United Kingdom.

Baharam Bodaghi (B)

Department of Ophthalmology, Sorbonne University, Paris, France.

Talin Barisani-Asenbauer (T)

OCUVAC-Centre of Ocular Inflammation and Infection, Laura Bassi Centre of Expertise, Center of Pathophysiology, Infectiology & Immunology, Medical University of Vienna, Vienna, Austria.

Peter McCluskey (P)

Save Sight Institute, Department of Ophthalmology, University of Sydney, Sydney, Australia.

Aniruddha Agarwal (A)

Advanced Eye Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

John H Kempen (JH)

Department of Ophthalmology, Massachusetts Eye and Ear Infirmary and Harvard Medical School, Boston, Massachusetts; MyungSung Christian Medical Center (MCM) Eye Unit, MCM General Hospital and MyungSung Medical School, Addis Abeba, Ethiopia.

Amod Gupta (A)

Advanced Eye Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Justine R Smith (JR)

Flinders University College of Medicine and Public Health, Adelaide, Australia.

Marc D de Smet (MD)

MIOS SA-Medical/Surgical Retina and Ocular Inflammation, Lausanne, Switzerland.

Yew Sen Yuen (YS)

Department of Ophthalmology, National University Hospital, Singapore, Republic of Singapore.

Sarakshi Mahajan (S)

St. Joseph Mercy Hospital, Oakland, Pontiac, Michigan.

Onn Min Kon (OM)

Chest and Allergy Clinic, St. Mary's Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.

Quan Dong Nguyen (QD)

Byers Eye Institute, Stanford Medical School, Stanford, California.

Carlos Pavesio (C)

Moorfields Eye Hospital and Biomedical Research Centre, Institute of Ophthalmology, University College London, London, United Kingdom.

Vishali Gupta (V)

Advanced Eye Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India. Electronic address: vishalisara@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH